Patients use AI self-diagnosis tools because this technology offers quick answers, helps overcome difficulties in accessing care, appeals to patients who distrust health care providers or wish to ...

SGLT-2 inhibitors were linked to lower risk for autoimmune rheumatic diseases in those with diabetes compared with sulfonylureas.

Despite being a first-line treatment for CHE, nearly 40% of patients treated with TCS had inadequate treatment response or contraindications to TCS.

More than 1 in 5 young adults use a substance to get to sleep, with cannabis use more common than alcohol use.

During their most recent nonfatal overdose, 82.15% of survivors reported naloxone use and 47.0% reported a visit to the emergency department.

Disease activity and multimorbidity among patients in the US with PsA varied based on geographic region, socioeconomic deprivation, race, and gender.

At least 123 people have been infected during a growing measles outbreak along the Utah-Arizona border in recent weeks.

Cecilia Bahit, MD, and Carolyn Lam, MBBS, PhD, FACC, discuss the barriers patients face when seeking access to clinical trial ...

The FDA will move select drugs through the approval process in 1 to 2 months rather than the standard 10 months.

The use of ROM terminology on pathology requisition forms has a relatively low positive predictive value for a diagnosis of melanoma.

Adjuvant cemiplimab may reduce the risk of second primary tumors in patients with high-risk cutaneous squamous cell carcinoma, data suggest.

The FDA has expanded the approval of Yuflyma (adalimumab-aaty) and its unbranded version to include the treatment of HS in patients aged 12 years and older and UV in pediatric patients aged 2 years ...